Feasibility and acceptability of a mental health screening tool and training programme in the youth alcohol and other drug (AOD) sector

Drug and Alcohol Review

Volumn 26, Issue 5, 2007, Pages 509-515

  Hides, Leanne ^a   Lubman, Dan I ^a   Elkins, Kathryn ^a,b   Catania, Lisa S ^a   Rogers, Nich ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WESTERN HEALTH   (Australia)

^c Youth Substance Abuse Service   (Australia)

Author keywords

Comorbidity; Drug abuse; Mental health; Screening; Training; Young people

Indexed keywords

ADDICTION; ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; CHILD HEALTH CARE; DRUG DEPENDENCE TREATMENT; EDUCATION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MALE; MASS SCREENING; MENTAL DISEASE; MENTAL HEALTH SERVICE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PSYCHIATRIC DIAGNOSIS; PSYCHOMETRY; QUESTIONNAIRE;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; ADULT; AUSTRALIA; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; MALE; MASS SCREENING; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOMETRICS; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 34547959587     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701499126     Document Type: Article

References (34)

1. Kandel DB, Johnson JG, Bird HR, et al. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA study. J Am Acad Child Adolesc Psychiatry 1999;38:693-9.
2. Kessler R, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony J. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:313-21.
3. Lewinsohn PM, Hops H, Roberts RE, et al. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993;102:133-44.
4. Bukstein OG, Glancy LG, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry 1992;31:1041-5.
5. Kramer TL, Robbins JM, Phillips SD, Miller TL, Burns BJ. Detection and outcomes of substance use disorders in adolescents seeking mental health treatment. J Am Acad Child Adolesc Psychiatry 2003;42:1318-26.
6. Clark DA, Pollock NK, Bukstein OG, Mezzich AC, Bromberger J, Donovan J. Gender and comorbid psychopathology in adolescents in alcohol dependence. J Am Acad Child Adolesc Psychiatry 1997;36:1195-203.
7. Lubman DI, Allen NB, Rogers N, Cementon E, Bonomo Y. The impact of co-occurring mood and anxiety disorders among substance-abusing youth. J Affect Disord in press.
8. DiMileo L. Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry 1989;146:1212-14.
9. Fridell M, Hesse M. Psychiatric severity and mortality in substance abusers a 15-year follow-up of drug users. Addict Behav 2006;31:559-65.
10. King RD, Gaines LS, Lambert EW, Summerfelt WT, Bickman L. The co-occurrence of psychiatric substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. J Behav Health Serv Res 2000;27:417-30.
11. Kavanagh DJ, Mueser KT, Baker A. Management of comorbidity. In: Teesson M, Proudfoot H, eds. Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Sydney: Commonwealth of Australia, 2003:78-120.
12. Hides L, Elkins K, Catania LS, Mathias S, Kay-Lambkin F, Lubman DI. Feasibility and outcomes of an innovative cognitive-behavioural skill training programme for co-occurring disorders in the youth alcohol and other grug (AOD) sector. Drug Alcohol Rev 2007; 26:517-23.
13. Hides L, Lubman DI, Devlin H, et al. The reliability and validity of KlO and PHQ amongst injecting drug users. Aust NZ J Psychiatry 2007;41:166-8.
14. Kavanagh DJ, Baker A, Teesson M. Co-morbidity of mental disorders and substance misuse: introduction. Drug Alcohol Rev 2004;23:405-6.
15. Roche AM, Pollard Y. Improved services for people with drug and alcohol problems and mental illness: assisting alcohol and other drugs (AOD) non-government organisations to better respond to people with co-morbid AOD and mental health issues. Adelaide: National Centre for Education and Training on Addiction (NCETA), Flinders University, 2006.
16. Cottler LB, Grant BF, Blaine J, et al. Concordance of the DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend 1997;47:195-205.
17. Kranzler HR, Kadden RM, Babor TF, Tennen H. Validity of the SCID in substance abuse patients. Addiction 1996;91:859-68.
18. Dawe S, Loxton N, Hides L, Kavanagh D, Mattick R. Review of diagnostic screening instruments for alcohol and other drug use and other psychiatric disorders. NDARC Monograph no. 48, 2nd edn. Sydney: National Drug and Alcohol Research Centre, 2002.
19. Franken IH, Hendriks VM. Screening and diagnosis of anxiety and mood disorders in substance abuse patients. Am J Addict 2001;10:30-9.
20. Rounsaville BJ, Weissman MM, Rosenberger PH, Wilber CW, Kleber HD. Detecting depressive disorders in drug abusers. J Affect Disord 1979;1:255-67.
21. Weiss RD, Griffin ML, Mirin SM. Diagnosing major depression in cocaine abusers: the use of depression rating scales. Psychiatr Res 1989;28:335-43.
22. Zimmerman M, Sheeran T, Chelminski I, Young D. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. J Subst Abuse Treat 2004;26:181-8.
23. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003;60:184-9.
24. Andrews G, Slade T. Interpreting scores on the Kessler psychological distress scale (K10). Aust NZ J Psychiatry 2001;25:494-7.
25. Lecrubier Y, Sheehan DV, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997;12:224-31.
26. Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of Prime-MD: the PHQ primary care study. JAMA 1999;282:1737-44.
27. Johnson JG, Harris ES, Spitzer RL, Williams JBW. The Patient Health Questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health 2002; 30:196-204.
28. Degenhardt L, Hall W, Korten A, Jablensky A. Use of a brief screening instrument for psychosis: results of an ROC analysis. NDARC Technical Report 210. Sydney: National Drug and Alcohol Research Centre, 2005.
29. Degenhardt L, Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Weil-Being. Psychol Med 2001;31:659-68.
30. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232-41.
31. World Health Organisation ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability, and feasibility. Addiction 2002;97:1183-94.
32. Jorm AF, Christensen H, Griffiths KM. The public's ability to recognize mental disorders and their beliefs about treatment: changes in Australia over 8 years. Aust NZ J Psychiatry 2006;40:36-41.
33. Kisely S, Scott A, Denney J, Simon G. Duration of untreated symptoms in common mental disorders: association with outcomes: international study. Br J Psychiatry 2006;189:79-80.
34. Seivewright H, Tyrer P, Johnson T. Prediction of outcome in neurotic disorder: a 5-year prospective study. Psychol Med 1998;28:1149-57.